Quadrant Capital Group LLC Bausch Health Companies Inc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 4,426 shares of BHC stock, worth $32,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,426

Previous 4,114 7.58%

Holding current value

$32,708

Previous $28,000 28.57%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.22 - $8.26 $1,628 - $2,577	312 Added 7.58%	4,426 $36,000
Q2 2024 Aug 12, 2024	BUY	$6.1 - $10.41 $3,190 - $5,444	523 Added 14.56%	4,114 $28,000
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $481 - $657	-62 Reduced 1.7%	3,591 $38,000
Q4 2023 Feb 08, 2024	SELL	$6.53 - $8.23 $13 - $16	-2 Reduced 0.05%	3,653 $29,000
Q2 2023 Aug 09, 2023	SELL	$5.72 - $8.8 $2,196 - $3,379	-384 Reduced 9.51%	3,655 $29,000
Q4 2022 Feb 10, 2023	SELL	$6.09 - $7.93 $11,035 - $14,369	-1,812 Reduced 30.97%	4,039 $25,000
Q3 2022 Nov 10, 2022	BUY	$4.58 - $9.21 $21,645 - $43,526	4,726 Added 420.09%	5,851 $40,000
Q2 2022 Aug 09, 2022	SELL	$7.06 - $23.63 $13,152 - $44,022	-1,863 Reduced 62.35%	1,125 $9,000
Q1 2022 May 06, 2022	SELL	$21.6 - $27.79 $20,584 - $26,483	-953 Reduced 24.18%	2,988 $68,000
Q4 2021 Feb 01, 2022	BUY	$23.0 - $29.01 $23,115 - $29,155	1,005 Added 34.23%	3,941 $109,000
Q3 2021 Nov 12, 2021	BUY	$25.04 - $30.06 $4,382 - $5,260	175 Added 6.34%	2,936 $82,000
Q2 2021 Aug 09, 2021	BUY	$27.43 - $32.7 $13,440 - $16,023	490 Added 21.58%	2,761 $81,000
Q1 2021 May 12, 2021	BUY	$21.37 - $34.38 $4,103 - $6,600	192 Added 9.24%	2,271 $72,000
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $9,982 - $13,770	652 Added 45.69%	2,079 $43,000
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $1,413 - $1,912	95 Added 7.13%	1,427 $22,000
Q2 2020 Aug 13, 2020	SELL	$13.31 - $20.51 $39,357 - $60,648	-2,957 Reduced 68.94%	1,332 $24,000
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $2,076 - $4,840	160 Added 3.88%	4,289 $65,000
Q4 2019 Feb 03, 2020	SELL	$18.89 - $31.89 $94,487 - $159,513	-5,002 Reduced 54.78%	4,129 $122,000
Q2 2019 Jul 24, 2019	BUY	$20.52 - $26.45 $30,718 - $39,595	1,497 Added 19.61%	9,131 $228,000
Q1 2019 Apr 29, 2019	BUY	$20.23 - $26.29 $34,067 - $44,272	1,684 Added 28.3%	7,634 $186,000
Q4 2018 Jan 17, 2019	BUY	$17.64 - $28.32 $21,362 - $34,295	1,211 Added 25.55%	5,950 $105,000
Q3 2018 Oct 29, 2018	BUY	$20.64 - $25.67 $97,812 - $121,650	4,739 New	4,739 $118,000

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Bausch Health Companies Inc. Transaction History